SHAREH GHANI: Open Payments
NPI 1366520488 · FREMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 13 payments from 6 companies in 2025. Trend: 2023 $876 · 2024 $786 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $221 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: LYBALVI, ARISTADA, FANAPT, COBENFY, AUSTEDO XR, REXULTI, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
